Marca Nominativa depositada no INPI em 26/03/2021 por Roche Diabetes Care GmbH, processo nº 501603503, nas classes 09, 10, 42. Registro em vigor até 26/03/2031.
| Número do processo | 501603503 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 26/03/2021 |
| Data da concessão | 02/04/2024 |
| Vigência até | 26/03/2031 |
| Titular | Roche Diabetes Care GmbH |
| CNPJ/CPF do titular | — |
| UF · País | — · DE |
Electronic media for the transmission, storage and digital processing of medical data and values provided by medical instruments and apparatus; software and databases, computer hardware and/or software for displaying and analyzing values provided by medical apparatus and instruments; software and data banks, namely, computer hardware and/or software for managing patient data; remote controls for medical instruments and apparatus.;
Medical instruments and apparatus for diagnostic purposes in the treatment of diabetes; infusion pumps, infusion sets, containers, control and regulation; medical apparatus for measuring and displaying body fluid measurements in the treatment of diabetes, especially blood glucose, and accessories thereof included in this class; blood glucose meters and accessories thereof included in this class; lancets, lancing devices and accessories thereof included in this class; apparatus for measuring, signaling and monitoring for diagnostic and medical purposes.;
Design and development of computer software in the field of healthcare organizations and solutions; platform as a service [PaaS] in the medical field; hosting a website featuring resources, namely, non-downloadable software for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients; providing on-line, non-downloadable, Internet-based software application for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients; software as a service (SaaS) services featuring software for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients; providing non-downloadable software for recording, analyzing, transmitting and monitoring information in the field of diabetes therapy management.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501603503 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas6 despacho(s) publicado(s) na Revista da Propriedade Industrial.